Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1411268Generated: October 31, 2026

Chlorosulfonic acid → HCID 90449895, compound

https://huagongshe.com/reaction/1411268

Reaction equation

Participants

RoleNameHCIDCharge
ReactantChlorosulfonic acidHCID 24638—
Reactant1-MethylpiperazineHCID 53167—
ReactantDiisopropylethylamineHCID 81531—
ReactantHCID 90449878HCID 90449878—
SolventWaterHCID 962—
SolventDichloromethaneHCID 6344—
ProductHCID 90449895HCID 9044989582%

Reaction Steps

1-(1′-Acetylspiro[indoline-3,3′-pyrrolidin]-1-yl)-2,2,2-trifluoroethanone (1.19 g, 3.81 mmol) was dissolved in methylene chloride (10 mL). Thereafter, chlorosulfonic acid (1.27 mL, 19 mmol) was added to the above obtained solution under cooling on ice, and the thus obtained mixture was then stirred for 30 minutes. Thereafter, while stirring, the reaction solution was added dropwise to ice water, and was then extracted with chloroform. The obtained organic layer was washed with brine, and was then dried over anhydrous sodium sulfate, followed by concentration in vacuo. The obtained residue was dissolved in methylene chloride (20 mL). Thereafter, N,N-diisopropylethylamine (0.7 mL, 4 mmol) and 1-methylpiperazine (0.22 mL, 2 mmol) were added to the above obtained solution under cooling on ice, and the thus obtained mixture was then stirred at room temperature for 15 hours. Thereafter, the reaction solution was diluted with water, and was then extracted with chloroform. The obtained organic layer was washed with brine, and was then dried over anhydrous sodium sulfate, followed by concentration in vacuo. The obtained residue was dissolved in methanol (3 mL), and a saturated solution of ammonium-methanol (3 mL) was then added to the above obtained solution, followed by stirring the mixture at room temperature for 30 minutes. Thereafter, the reaction solution was concentrated in vacuo, and the obtained residue was then purified by silica gel column chromatography (chloroform:methanol=10:1) to obtain 1-(5-((4-methylpiperazin-1-yl)sulfonyl)spiro[indoline-3,3′-pyrrolidin]-1′-yl)ethanone (559 mg, 82%) in the form of a white solid.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08921576B2
Source datasetuspto-grants-2014_12
ORD IDord-711381777e4e4fd2bd7c9ae8159a6138
Source noteuspto-grants-2014_12